Predictors of Warfarin Time in Therapeutic Range after Continuous‐Flow Left Ventricular Assist Device

Autor: Ian B. Hollis, Amanda C. Coniglio, Jason N. Katz, Prashanth Iyer, Christopher V. Chien, James B Henderson
Rok vydání: 2019
Předmět:
Zdroj: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 39:1030-1035
ISSN: 1875-9114
0277-0008
DOI: 10.1002/phar.2324
Popis: Introduction Patients with a continuous-flow left ventricular assist device (CF-LVAD) require anticoagulation with a vitamin K antagonist to prevent thromboembolic events. Fluctuations in the international normalized ratio are associated with both increased thrombotic and bleeding episodes. To date, risk factors for low time in therapeutic range (TTR) among ambulatory patients with a CF-LVAD have not been explored. Methods A retrospective single-center analysis of 121 patients implanted with a CF-LVAD was performed. International normalized ratios were systematically recorded from the initial postdischarge outpatient visit to 12 months of time on the device. Risk factors for low TTR were evaluated using a multivariable linear regression analysis. Each of the 21 independent variables was entered into a stepwise regression designed to minimize the Akaike information criteria. Results In the multivariable analysis, the model output revealed that every 1-year increase in age was associated with a 0.4% increase in TTR (p=0.008), and every 1 mile further from clinic was associated with a 0.08% increase in TTR (p=0.03). Female sex was associated with a 10.1% decrease in TTR (p=0.04), type 2 diabetes was associated with an 11.5% decrease in TTR (p=0.006), and prior warfarin use was associated with an 8.3% decrease in TTR (p=0.03). Conclusion In CF-LVAD recipients receiving warfarin, increasing age and distance from clinic are independent predictors of higher TTR. Female sex, type 2 diabetes, and prior warfarin use are independent predictors of lower TTR.
Databáze: OpenAIRE
Externí odkaz: